Patent: 6,197,505

Try a free trial See Plans and Pricing

« Back to Dashboard

Summary for Patent: 6,197,505

Title:	Methods for assessing cardiovascular status and compositions for use thereof
Abstract:	The present invention provides methods for assessing cardiovascular status in an individual, which comprise determining the sequence at one or more polymorphic positions within the human genes encoding angiotensin converting enzyme (ACE), angiotensinogen (AGT), and/or type 1 angiotensin II receptor (AT1). The invention also provides isolated nucleic acids encoding ACE, AGT, and AT1 polymorphisms, nucleic acid probes that hybridize to polymorphic positions, kits for the prediction of cardiovascular status, and nucleic acid and peptide targets for use in identifying candidate cardiovascular drugs.
Inventor(s):	Norberg; Leif Torbjorn (Uppsala, SE), Andersson; Maria Kristina (Uppsala, SE), Lindstrom; Per Harry Rutger (Uppsala, SE)
Assignee:	Pyrosequencing AB (Uppsala, SE)
Application Number:	09/050,159
Patent Claims:	see list of patent claims

Details for Patent 6,197,505

Glossary

Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Patent Expiration	Status	Orphan	Source
Schering	INTRON A	interferon alfa-2b	VIAL	103132	003	1986-06-04	➤ Try a Free Trial	Pyrosequencing AB (Uppsala, SE)	➤ Try a Free Trial	RX		search
Schering	INTRON A	interferon alfa-2b	VIAL	103132	002	1986-06-04	➤ Try a Free Trial	Pyrosequencing AB (Uppsala, SE)	➤ Try a Free Trial	RX		search
Schering	INTRON A	interferon alfa-2b	VIAL	103132	001	1986-06-04	➤ Try a Free Trial	Pyrosequencing AB (Uppsala, SE)	➤ Try a Free Trial	RX		search
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Patent Expiration	Status	Orphan	Source

International Patent Family for US Patent 6,197,505

Subscribe to access the full database, or try a Free Trial
Country	Patent Number	Publication Date
World Intellectual Property Organization (WIPO)	9845477	Jan 28, 1999
World Intellectual Property Organization (WIPO)	9845477	Oct 15, 1998
New Zealand	337878	Sep 28, 2001
Country	Patent Number	Publication Date

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.